In light of the recent findings that TMEM106B can form protein aggregates commonly seen in patients with neurodegenerative diseases, we here propose a model that reconciles the phenotype of TMEM106B deficiency and overexpression. This evidence concerns the gene TMEM106B and neurodegenerative disease.